Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial co ...
The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...
The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...
With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...
Melbourne-based scientists have, for the first time, discovered how to "switch off" a molecule which is one of the top ...
The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback